Fibroblast growth factor 23 (FGF23), an endocrine FGF subfamily protein, can increase urinary phosphate excretion and decrease intestinal phosphate absorption to counteract high phosphorus load in CKD patients (9, 10). This evidence concerns the gene FGF23 and chronic kidney disease.